BfArM/PEI: Guideline "Designation of Medicinal Products" published
![Drug Master File Procedures in the EU, the US and Japan - Live Online Training](files/eca/userImages/training.img/Z-ECA-Drug-Master-File-Procedures-LOT.jpg)
Recommendation
17/18 September 2024
With updates on the CEP 2.0!
The German BfArM (Federal Institute for Drugs and Medical Devices) and the German PEI (Paul Ehrlich Institute - the Federal Institute for Vaccines and Biomedicines) published version 8.2 of the "Guideline on the Designation of Medicinal Products" (Leitlinie zur Bezeichnung von Arzneimitteln) at the end of July, which can be viewed on both websites of the institutes. The above-mentioned guideline was fundamentally revised in 2023 and applies exclusively to medicinal products for human use. It is intended to support marketing authorisation holders and applicants in the selection of the designation of the respective medicinal products.
The new version consists of 9 chapters, Annex 1 "List of possible designation supplements" and three annexes on references. Chapters 4, 5, 6 and 7 are each subdivided into subchapters. In addition to the elements of the medicinal product designation (Chapter 3), the general requirements for the medicinal product designation (Chapter 4) as well as the pharmaceutical dosage form (Chapter 8) and strength (Chapter 7) are discussed and explained. Further topics are presented and described in Chapter 5 Phantasy Names and in Chapter 6 Generic Drug Designations.
The new version 8.2 of the "Leitlinie des BfArM und des PEI zur Bezeichnung von Arzneimitteln" (Guideline on the Designation of Medicinal Products) can be viewed on the BfArM website (in German only).
Related GMP News
17.07.2024EMA: Q&A document for "Centralised Procedures" updated again
16.07.2024CMDh/HMA: New Update of the Q&A List on Variations
18.06.2024EDQM: New Guideline for sterile Substances published for Comment
18.06.2024EMA updates IRIS Guide
02.05.2024EDQM: Updated Information on the Quality Overall Summary (Module 2)
02.05.2024EDQM: Manufacturing Sites in CEP 2.0?